Mohamed Boudifa

Dr. Mohamed Boudifa

Plasma Surface, CRITT Matériaux Innovation, Charleville-Mézières, Grand Est, France

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ILIvan López-González
Ivan López-González
Ana Belén Hernández HerediaAna Belén Hernández Heredia
Ana Belén Hernández Heredia
MRMaría I. Rodríguez-López
María I. Rodríguez-López
DCDAVID AUÑÓN CALLES
DAVID AUÑÓN CALLES
MBMohamed Boudifa
Mohamed Boudifa
LMLuis Meseguer-Olmo
Luis Meseguer-Olmo
Acute and chronic bone infections, especially those caused by methicillin-resistant Staphylococcus aureus (MRSA), remains a major complication and therapeutic challenge. It is documented that local administration of vancomycin offers better results than the usual routes of administration (e.g., intravenous) when ischemic areas are present. In this work, we evaluate the antimicrobial efficacy against S. aureus and S. epidermidis of a novel hybrid 3D-printed scaffold based on polycaprolactone (PCL) and a chitosan (CS) hydrogel loaded with different vancomycin (Van) concentrations (1, 5, 10, 20%). Two cold plasma treatments were used to improve the adhesion of CS hydrogels to the PCL scaffolds by decreasing PCL hydrophobicity. Vancomycin release was measured by means of HPLC, and the biological response of ah-BM-MSCs growing in the presence of the scaffolds was evaluated in terms of cytotoxicity, proliferation, and osteogenic differentiation. The PCL/CS/Van scaffolds tested were found to be biocompatible, bioactive, and bactericide, as demonstrated by no cytotoxicity (LDH activity) or functional alteration (ALP activity, alizarin red staining) of the cultured cells and by bacterial inhibition. Our results suggest that the scaffolds developed would be excellent candidates for use in a wide range of biomedical fields such as drug delivery systems or tissue engineering applications.